With a fully-fledged research laboratory facility undertaking immunological, molecular and microbiological assays, Wits VIDA is firmly established as a leading research unit in Africa on vaccine preventable diseases. The unit’s laboratory has an array of immunology assays targeted at analysing immune responses to the majority of vaccines included in public immunisation programmes, as well as against future possible vaccine targets (e.g. GBS,RSV and SARS-CoV-2). A broad range of techniques are utilised and include custom designed assays on the Luminex platform and traditional ELISA’s.
In addition, the unit has an array of high throughput multiplex PCR assays for the detection of RSV, Influenza, Pertussis, HMPV and SARS-CoV-2 to name but a few. The laboratory is also equipped with Fluidigm, TaqMAN array and Microarray. We are also expanding into Next Generation Sequencing which is aimed at further elucidating the etiology of disease.
The laboratory is assisted by a team who are practiced in the handling and processing of a variety of biological samples. Samples are archived in an existing biorepository which hold a large collection of historical samples spanning more than 15 years of research. The work of the unit is supported by a dedicated data management and analytical team.